Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation

The Journal of Clinical Investigation
T HirataS Narumiya

Abstract

Thromboxane A2 (TXA2) receptor is a key molecule in hemostasis as its abnormality leads to bleeding disorders. Two isoforms of the human TXA2 receptor have been cloned; one from placenta and the other from endothelium, here referred to as TXR alpha and TXR beta, respectively. These isoforms differ only in their carboxyl-terminal tails. We report that both isoforms are present in human platelets. The two isoforms expressed in cultured cells show similar ligand binding characteristics and phospholipase C (PLC) activation but oppositely regulate adenylyl cyclase activity; TXR alpha activates adenylyl cyclase, while TXR beta inhibits it. The Arg60 to Leu mutant of TXR alpha, which has been shown to impair PLC activation (Hirata, T., A. Kakizuka, F. Ushikubi, I. Fuse, M. Okuma, and S. Narumiya. 1994. J. Clin. Invest. 94: 1662-1667), also impairs adenylyl cyclase stimulation, whereas that of TXR beta retains its activity to inhibit adenylyl cyclase. These findings suggest that the pathway linked to adenylyl cyclase inhibition might be involved in some of the TXA2-induced platelet responses such as shape change and phospholipase A2 activation which remain unaffected in the patients with this mutation.

References

Jan 1, 1978·Annual Review of Biochemistry·B SamuelssonC Malmsten
Sep 11, 1990·Nucleic Acids Research·S Mizushima, S Nagata
Jan 1, 1989·Annual Review of Pharmacology and Toxicology·P V HalushkaT A Morinelli
Apr 1, 1973·Virology·F L Graham, A J van der Eb
Jun 1, 1984·Journal of Medical Genetics·S VandenplasC Måthew
Mar 24, 1995·The Journal of Biological Chemistry·M K RaychowdhuryJ A Ware
Oct 1, 1994·The Journal of Clinical Investigation·T HirataS Narumiya
Mar 29, 1994·Proceedings of the National Academy of Sciences of the United States of America·I F CharoS R Coughlin
Jan 29, 1993·Cell·L L LinR J Davis

❮ Previous
Next ❯

Citations

Apr 12, 2012·Cellular and Molecular Life Sciences : CMLS·Scott GleimJohn Hwa
Aug 25, 2010·Internal and Emergency Medicine·Francesca SantilliGiovanni Davì
Jan 31, 2004·Cellular Signalling·Jin-Sheng HuangGuy C Le Breton
May 22, 2013·European Journal of Medicinal Chemistry·Sylvie-Mireille Bambi-NyanguileBernard Pirotte
Aug 19, 2003·European Journal of Pharmacology·Valérie CapraG Enrico Rovati
Jul 28, 1999·European Journal of Pharmacology·N NakahataY Ohizumi
Jan 29, 2000·European Journal of Pharmacology·J L CracowskiP Devillier
Jan 16, 2002·Prostaglandins & Other Lipid Mediators·Frances MooreBernal Andrés López
Nov 16, 2002·Prostaglandins & Other Lipid Mediators·Kazuhito TsuboiAtsushi Ichikawa
Feb 7, 2001·Prostaglandins & Other Lipid Mediators·P V Halushka
Jun 17, 2000·Progress in Lipid Research·Y SugimotoA Ichikawa
Mar 1, 1997·Progress in Lipid Research·J D Morrow, L J Roberts
Jul 3, 1999·Trends in Pharmacological Sciences·G J KilpatrickR M Eglen
Jan 22, 2004·Critical Reviews in Oncology/hematology·Indra Ramasamy
Aug 9, 2011·Chemical Reviews·Takako Hirata, Shuh Narumiya
Sep 15, 1998·Kidney International. Supplement·D W Thomas, T M Coffman
May 11, 2002·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·N A SharifS X Xu
Jan 15, 2005·Antioxidants & Redox Signaling·Kamal F Badr, Tania E Abi-Antoun
Mar 30, 2013·Arteriosclerosis, Thrombosis, and Vascular Biology·Jinlong HeMing-Hui Zou
Apr 6, 2006·Biological & Pharmaceutical Bulletin·Katsutoshi MiyosawaNorimichi Nakahata
Jan 5, 2007·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Norimichi Nakahata, Masaki Saito
Jun 15, 2010·Clinical Lipidology·Emer M Smyth
Sep 3, 2013·Pflügers Archiv : European journal of physiology·Takahiro ShimizuHideki Sakai
Dec 20, 2013·Journal of Cardiovascular Translational Research·P FontanaJ-L Reny
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·J Jin, S P Kunapuli
Jun 6, 1998·Proceedings of the National Academy of Sciences of the United States of America·G R WangM E Mendelsohn
Nov 12, 2005·Critical Reviews in Clinical Laboratory Sciences·Miles D ThompsonDavid E C Cole
Dec 30, 2014·Expert Review of Respiratory Medicine·Dru ClaarRay Stokes Peebles
May 22, 2013·Scandinavian Cardiovascular Journal : SCJ·Zanxin WangMinxin Wei

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.